.jpg "HoJin Shin, BPharm, PhD photo")
Postdoctoral Research Fellow
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
HoJin Shin, BPharm, PhD is a postdoctoral research fellow in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. She graduated with a Bachelor of Pharmacy and a Master of Pharmacy from Seoul National University (South Korea). She earned a Doctor of Philosophy degree in Population Health Sciences at Harvard Graduate School of Arts and Sciences and a Master of Science in Pharmacoepidemiology at Harvard T.H. Chan School of Public Health. Her doctoral dissertation evaluated the use of a novel glucose-lowering therapy, sodium-glucose cotransporter-2 inhibitors (SGLT-2i), as first-line treatment for type 2 diabetes using large US claims databases. Her postdoctoral work has focused on bridging the gap between randomized controlled trial (RCT) findings and real-world evidence (RWE), involving generalization of RCT results to target populations and linkage between individual trial participants and their claims data to investigate the root causes of discrepancies between RCT results and RWE and assess how each database could complement the other.
